B cells as therapeutic targets for rheumatic diseases

RJ Looney, J Anolik, I Sanz - Current opinion in rheumatology, 2004 - journals.lww.com
RJ Looney, J Anolik, I Sanz
Current opinion in rheumatology, 2004•journals.lww.com
B cells as therapeutic targets for rheumatic diseases : Current Opinion in Rheumatology B cells
as therapeutic targets for rheumatic diseases : Current Opinion in Rheumatology Log in or
Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal
Logo Advanced Search Toggle navigation Subscribe Register Login Articles & Issues Videos
For Authors Journal Info Advanced Search May 2004 - Volume 16 - Issue 3 Previous Article
Next Article Clinical therapeutics B cells as therapeutic targets for rheumatic diseases Looney …
Summary
Several therapeutic agents targeting B cells have now been tested or are being tested in human trials. The success of rituximab in a well-controlled trial confirms previous preliminary reports indicating that B cell depletion can treat established autoimmune disease.
Lippincott Williams & Wilkins
Show moreShow less
Save Cite Cited by 121 Related articles All 7 versions